Related Experiment Video
Updated: Jun 2, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Serum level of heart-type Fatty Acid-binding protein in patients with chronic renal failure
Hafidh A Al-Hadi1, Brent William, Keith A Fox
1Department of Medicine, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman;
Insights
Heart-type fatty acid binding-protein (H-FABP) and cardiac troponin (cTnT) levels are elevated in patients with renal failure. This suggests their diagnostic efficiency for acute myocardial infarction (AMI) may be limited in this population.
Area of Science:
- Cardiovascular Biomarkers
- Renal Medicine
- Clinical Diagnostics
Background:
- Heart-type fatty acid binding-protein (H-FABP) is a potential early diagnostic marker for acute myocardial infarction (AMI).
- The impact of kidney disease on H-FABP levels is not well understood.
- Renal failure may affect the interpretation of cardiac biomarkers.
Purpose of the Study:
- To compare H-FABP and cardiac troponin (cTnT) concentrations in patients with renal failure.
- To evaluate the influence of renal failure on these cardiac biomarkers.
Main Methods:
- A cohort of 16 patients with renal failure undergoing dialysis was studied.
- Serum levels of H-FABP and cTnT were measured.
Main Results:
- All patients (100%) showed elevated H-FABP levels (mean ±SD: 81 ±53.3μg/L).
- Elevated cTnT levels (≥ 0.1μg/L) were observed in 50% of patients.
- Significant renal dysfunction was confirmed by high urea and creatinine levels.
Conclusions:
- H-FABP and cTnT may have limited diagnostic value for AMI in patients with renal failure.
- Elevated levels of these biomarkers can occur in renal failure patients even without AMI.
Objectives:
Heart-type fatty acid binding-protein (H-FABP) has been reported to be a potential novel biochemical marker for the early diagnosis of acute myocardial infarction (AMI). The effect of kidney diseases on the renal handling of H-FABP has not yet been fully evaluated. The aim of this study was to compare the effect of renal failure on the level of H-FABP and cardiac troponin (cTnT) concentrations.
Methods:
The study population was a small group of 16 patients with renal failure (6 females, 10 males aged 30-70 years) on routine regular haemodialysis or peritoneal dialysis.
Results:
The mean ±SD of serum urea and creatinine concentration in this group of patients was 19 ±9.6 mmol/L and 531.3 ±231.2 mmol/L respectively. H-FABP was increased in all 16 patients (81 ±53.3μg/L). The cTnT was increased ≥ 0.1μg/L in 8 patients (50%), ≥ 0.2μg/L in 5 patients (31.3%), and ≥ 0.3μg/L in 1 patient (6%).
Conclusion:
The diagnostic efficiency of H-FABP and cTnT for the diagnosis of AMI in the presence of renal failure may be limited and such patients may have high levels even in the absence of AMI.
Related Concept Videos
Serum Studies: Renal Function Tests
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure VI: Adjunct Therapies
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
